Effect of antibodies to morphine on synaptic plasticity of the hippocampus.

Bull Exp Biol Med

Institute of Molecular Biology and Biophysics, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk.

Published: February 2003

Incubation of hippocampal slices with antibodies to morphine did not change the total excitatory postsynaptic potential of mossy fibers, but markedly facilitated long-term posttetanic potentiation. Culturing of the organotypic hippocampal culture in the presence of 10 microM morphine increased the total excitatory postsynaptic potential of mossy fibers and reduced the probability of long-term posttetanic potentiation.

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1023895109474DOI Listing

Publication Analysis

Top Keywords

antibodies morphine
8
total excitatory
8
excitatory postsynaptic
8
postsynaptic potential
8
potential mossy
8
mossy fibers
8
long-term posttetanic
8
posttetanic potentiation
8
morphine synaptic
4
synaptic plasticity
4

Similar Publications

While low-dose cannabinoid 2 (CB2) receptor agonists attenuate morphine tolerance in cancer pain models, chemokine ligand 12 (CXCL12)/chemokine receptor 4 (CXCR4) expression induces morphine tolerance. Whether CB2 receptor agonists attenuate morphine tolerance by modulating CXCL12/CXCR4 signaling or whether CXCL12/CXCR4 signaling affects the mu opioid receptor (MOR) in the development of morphine tolerance in cancer pain remains unclear. In this study, we investigated the attenuation of morphine tolerance by a non-analgesic dose of the CB2 receptor agonist AM1241, focusing specifically on the modulation of CXCL12/CXCR4 signaling and its effect on the MOR.

View Article and Find Full Text PDF

Background: Immune checkpoint inhibitors (ICIs) are becoming the standard of care for recurrent and metastatic cancer. Opioids, the primary treatment for cancer-related pain, are immunosuppressive raising concerns about their potential to interfere with the efficacy of ICIs. We hypothesize that exogenous opioids given for analgesia suppress antitumor immunity via T cell-mediated mu opioid receptor 1 (OPRM1) signaling.

View Article and Find Full Text PDF

New insights in the mechanisms of opioid analgesia and tolerance: Ultramicronized palmitoylethanolamide down-modulates vascular endothelial growth factor-A in the nervous system.

Pharmacol Res

November 2024

Department of Neuroscience, Psychology, DrugResearch and Child Health - NEUROFARBA - Section of Pharmacology andToxicology, University of Florence, Viale Pieraccini 6, Florence 50139, Italy.

Article Synopsis
  • Growing evidence shows that opioid analgesics, like morphine, can affect blood vessel formation (angiogenesis), which is linked to pain.
  • The study tested the effects of N-palmitoylethanolamine (PEA) and the anti-VEGF-A drug bevacizumab on morphine tolerance and pain relief, finding that PEA delays tolerance and enhances pain relief by reducing VEGF-A levels in the nervous system.
  • Both PEA and bevacizumab, when used with morphine, not only improved pain management but also decreased the expression of pain-related genes, suggesting a potential new approach to pain treatment that targets angiogenesis.
View Article and Find Full Text PDF

IgA binding dictates the composition of the intestinal microbiome and reflects dysbiotic states during chronic disease. Both pathogenic and commensal bacteria differentially bind to IgA with varying outcomes. Little is known regarding IgA dynamics immediately following microbial dysbiosis.

View Article and Find Full Text PDF
Article Synopsis
  • A method using Surface Enhanced Raman Spectroscopy (SERS) allows for the detection of methamphetamine, ketamine, and morphine by employing a specially prepared nanoporous gold membrane as a substrate.
  • The AuNPM substrate exhibited a low limit of detection (LOD) and was optimized using rhodamine 6G as a test analyte.
  • The approach involves a competitive immunoassay where drug-specific antigens on the substrate bind to corresponding antibodies, allowing for the qualitative and quantitative identification of the drugs based on changes in SERS intensity.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!